Nutritional Programme for Dementia Elderly Patient

Sponsor
Nestlé (Industry)
Overall Status
Completed
CT.gov ID
NCT00479843
Collaborator
Institut Català de l'envelliment, Barcelona, Spain (Other), Hospital Purpan (Other), NESTEC R&D, Switzerland (Other), Group MAPI-NAXIS, CRO, Lyon, France (Other)
946
1
24
39.4

Study Details

Study Description

Brief Summary

The main objective of this study is the improvement of the quality of life and state of health of elderly people with cognitive deterioration and their families through a weight loss prevention programme.

The secondary objectives are the improvement of the state of nutrition, a reduction in the use of resources and a reduction in the burden on the main carer.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Nutritional programme
N/A

Detailed Description

Main objective The main objective of this project is the evaluation of the effectiveness of a nutrition programme in patients with Alzheimer's or other dementias. Through the Nutrition Programme the idea is to reduce functional and weight loss in elderly people with cognitive deterioration and their families.

Evaluation of the effectiveness of the intervention

-The main evaluation criteria which will allow the effectiveness of this intervention to be evaluated are the reduction in the loss of autonomy measured by the DA/IDA scale.

Secondary objectives

The secondary objectives of this study are:
  • Improvement in the patient's state of nutrition The measurement criteria which will allow the patient's nutritional state to be evaluated will be their weight, BMI and MNA.

  • Reducing the burden on carers. The Zarit scale will be used for this evaluation.

  • Evaluation of the use of healthcare and social resources. The RUD scale will be used.

  • Improvement of medical practice regarding nutrition.

  • Evaluation of the representatives of our population with regard to the participation in a programme of these characteristics evaluating.

  • Evaluation of the satisfaction of elderly people and their families in relation to the programme.

Study Design

Study Type:
Interventional
Actual Enrollment :
946 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Development of a Programme to Show the Positive Effect of a Nutritional Programme on Preventing Functional and Weight Losses in Patients With Dementia
Study Start Date :
Jul 1, 2005
Actual Primary Completion Date :
Jul 1, 2007
Actual Study Completion Date :
Jul 1, 2007

Outcome Measures

Primary Outcome Measures

  1. Evaluation of the effectiveness of the intervention -The main evaluation criteria which will allow the effectiveness of this intervention to be evaluated are the reduction in the loss of autonomy measured by the DA/IDA scale. [Baseline, 6 months, 12 months]

Secondary Outcome Measures

  1. -Improvement in the patient's state of nutrition -Reducing the burden on carers with the Zarit scale. -Evaluation of the use of healthcare and social resources with the RUD scale. -Improvement of medical practice regarding nutrition. [Baseline, 6 months, 12 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
50 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • The patient has dementia according to DSM IV criteria.

  • The patient has an MMSE less than or equal to 26.

  • The patient lives in his/her home.

  • The patient is in the charge of a carer.

  • Informed consent for participation in the study by the responsible relative and, if possible, from the patient or legal guardian.

Exclusion Criteria:
  • The patient lives in an institution.

  • The patient is in a terminal situation.

  • The patient does not have a main carer.

  • Patient has a nasogastric feed.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Institut Català de l'envelliment Barcelona Spain 08041

Sponsors and Collaborators

  • Nestlé
  • Institut Català de l'envelliment, Barcelona, Spain
  • Hospital Purpan
  • NESTEC R&D, Switzerland
  • Group MAPI-NAXIS, CRO, Lyon, France

Investigators

  • Principal Investigator: Antoni SALVA, MD, SPAIN: Institut Català de l'envelliment

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00479843
Other Study ID Numbers:
  • 05.19.CLI
First Posted:
May 28, 2007
Last Update Posted:
Jan 24, 2014
Last Verified:
Jan 1, 2014
Keywords provided by , ,
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 24, 2014